Avalo Therapeutics (AVTX) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.3
-1.59
-0.88
-0.17

Details

Expected EPS
-1.65835
Actual EPS
-2.19
Surprise EPS
-0.53
Surprise Percent
-32.06%

Description

⁨Avalo Therapeutics⁩ (⁦AVTX⁩) has reported earnings of ⁦-2.19⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts